HomeCompareLTSAP vs PFE

LTSAP vs PFE: Dividend Comparison 2026

LTSAP yields 9.90% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LTSAP wins by $408890.34M in total portfolio value
10 years
LTSAP
LTSAP
● Live price
9.90%
Share price
$20.20
Annual div
$2.00
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$408890.39M
Annual income
$401,109,389,452.00
Full LTSAP calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — LTSAP vs PFE

📍 LTSAP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLTSAPPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LTSAP + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LTSAP pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LTSAP
Annual income on $10K today (after 15% tax)
$841.75/yr
After 10yr DRIP, annual income (after tax)
$340,942,981,034.20/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, LTSAP beats the other by $340,942,958,714.30/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LTSAP + PFE for your $10,000?

LTSAP: 50%PFE: 50%
100% PFE50/50100% LTSAP
Portfolio after 10yr
$204445.22M
Annual income
$200,554,707,855.36/yr
Blended yield
98.10%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

LTSAP
No analyst data
Altman Z
0.2
Piotroski
5/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LTSAP buys
0
PFE buys
0
No recent congressional trades found for LTSAP or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLTSAPPFE
Forward yield9.90%6.13%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%13.2%
Portfolio after 10y$408890.39M$49.6K
Annual income after 10y$401,109,389,452.00$26,258.71
Total dividends collected$408363.57M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: LTSAP vs PFE ($10,000, DRIP)

YearLTSAP PortfolioLTSAP Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$12,681$1,980.59$9,153$693.39+$3.5KLTSAP
2$18,263$4,694.41$8,593$849.25+$9.7KLTSAP
3$32,178$12,637.22$8,336$1,066.78+$23.8KLTSAP
4$76,050$41,619.48$8,437$1,384.80+$67.6KLTSAP
5$265,231$183,857.26$9,013$1,875.40+$256.2KLTSAP
6$1,482,332$1,198,535.32$10,306$2,680.72+$1.47MLTSAP
7$14,106,502$12,520,405.83$12,820$4,101.38+$14.09MLTSAP
8$237,803,240$222,709,283.18$17,673$6,826.70+$237.79MLTSAP
9$7,271,958,545$7,017,509,078.62$27,543$12,591.86+$7271.93MLTSAP
10$408,890,385,095$401,109,389,452.00$49,560$26,258.71+$408890.34MLTSAP

LTSAP vs PFE: Complete Analysis 2026

LTSAPStock

Ladenburg Thalmann Financial Services Inc. operates as a diversified financial services company in the United States. Its Independent Advisory and Brokerage Services segment offers advisory and securities brokerage services for clients, including advisor-managed accounts, general securities, mutual funds, and variable and fixed annuities; brokerage support services, such as access to stock, bond, exchange-traded fund, and options execution; insurance, non-traded real estate investment trusts, and unit trusts; and research, compliance, supervision, accounting, and related services. This segment also provides asset management services, trust administration of personal and retirement accounts, estate and financial planning, wealth management, and custody services. Its Ladenburg segment offers investment banking services consisting of corporate finance services, such as underwritten public, registered direct, and at-the-market offerings, as well as private investment in public equity and other private placements, and strategic and financial advisory services. This segment also provides investment research, sales and trading, investment, administration, operation, securities transactions processing, and customer accounts services; and various asset management products and services, including asset management programs, investment consulting services, fund management, private investment management programs, retirement plan sponsor services, alternative investments, architect programs, and third-party advisory services. Its Insurance Brokerage segment delivers life insurance, fixed, and equity-indexed annuities, as well as long-term care solutions to investment and insurance providers, marketing strategies, product expertise, and back-office processing for fixed and equity-indexed annuities. Ladenburg Thalmann Financial Services Inc. was formerly known as GBI Capital Management Corp and changed its name to Ladenburg Thalmann Financial Services Inc. in May 2001. The company was founded in 1876 and is headquartered in Miami, Florida with additional offices in Boca Raton, Florida; Princeton, New Jersey; Melville, New York; and New York, New York. Ladenburg Thalmann Financial Services Inc. operates as a subsidiary of AG Intermediate Corporation.

Full LTSAP Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this LTSAP vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LTSAP vs SCHDLTSAP vs JEPILTSAP vs OLTSAP vs KOLTSAP vs MAINLTSAP vs JNJLTSAP vs MRKLTSAP vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.